QA: Dynavax Technologies CORP in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2012_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 124,618,000
1 IntangibleAssetsNetIncludingGoodwill 2,312,000
2 PropertyPlantAndEquipmentNet 6,163,000
3 remainder_Assets 1,009,000
4 LiabilitiesCurrent 27,219,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,570,000
9 ResearchAndDevelopmentExpense 51,322,000
10 remainder_Expenses 2,256,000
11 remainder_Revenues 21,614,000
12 remainder_NetIncome 937,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 134,102,000
1 Liabilities 27,219,000
2 Expenses 71,148,000
3 Revenues 21,614,000
4 StockholdersEquity 106,883,000
5 NetIncome -48,597,000
6 ComprehensiveNetIncome -48,597,000
7 BaseVar 127,510,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.29
9 EconomicCapitalRatio 3.21

Edgar->Model Mapping

Feature Distribution